Details for Patent: 6,913,768
✉ Email this page to a colleague
Summary for Patent: 6,913,768
| Title: | Sustained release delivery of amphetamine salts |
| Abstract: | A pharmaceutical composition comprises a once-a-day sustained release formulation of at least one amphetamine salt which provides mean plasma concentration profile aspects in human ADHD patients which are substantially the same as that provided by ADDERALL XR.RTM. type pulsatile formulations. |
| Inventor(s): | Couch; Richard A. (Bryn Mawr, PA), Burnside; Beth A. (Bethesda, MD), Chang; Rong-Kun (Rockville, MD) |
| Assignee: | Shire Laboratories, Inc. (Rockville, MD) |
| Application Number: | 10/353,073 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,913,768 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 6,913,768
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,913,768
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| African Regional IP Organization (ARIPO) | 2030 | ⤷ Try a Trial | |||
| Austria | 495731 | ⤷ Try a Trial | |||
| Australia | 2003272619 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
